Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
With
Shaare Zedek Medical Center
Technion, Israel Institute of Technology
Age
18–49
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
CRC Cohort:
18-49 years old
Histological or cytological diagnosis of colorectal adenocarcinoma
Planned CRC resection biopsy, or colonoscopy ,including surveillance colonoscopies and/or have already undergone prior surgical resection, with tissue, including normal colonic mucosae distant from the malignant tumor (only patients providing tissue sample)
Enrollment in IRB# 20-315, Young Onset Gastrointestinal Cancer Prospective Registry (Andrea Cercek, PI)
Healthy Control Cohort:
18-49 years old at time of diagnosis
Scheduled for standard-of-care colonoscopy at MSK
Underwent surgical resection of a traumatic injury to the colon at Shaare Zedek Medical Center (SZMC)
You may not be if
CRC Cohort:
Antibiotic use within 6 months of collection of stool for gut microbiome analysis s (only patients providing stool sample)
Known inherited cancer susceptibility gene
History of inflammatory bowel disease
Healthy Control Cohort:
Antibiotic use within 6 months of collection of stool for gut microbiome analysis (only patients providing stool sample)
History of or prior treatment for cancer ≤ 5 years prior to registration. Exceptions include non-melanoma skin cancer, ductal carcinoma in situ, bladder carcinoma in situ, or carcinoma-in-situ of the cervix.
Colonoscopy for indications of IBD, anemia and/or genetic predisposition (only patients providing tissue sample).
